Australian panel consults on increasing transparency at TGA
This article was originally published in RAJ Devices
The committee that is reviewing the way in which Australia's Therapeutic Goods Administration communicates its regulatory processes and decisions to stakeholders is inviting feedback on how information about the agency's functioning can be better conveyed1.
You may also be interested in...
New guidance explains how UK-based sites and organizations can facilitate routine on-site good practice inspections that are due to restart next month.
A class review of Canadian product monographs for various insulin products has revealed inconsistencies.
A review of therapeutic goods advertising reforms that were introduced in Australia in 2018 calls for further changes to support implementation and compliance.